Design, synthesis, and evaluation of novel kazusamycin A derivatives as potent antitumor agents

Ryoichi Ando1, Yusaku Amano, Hideo Nakamura

  • 1Discovery Technology Laboratory II, Mitsubishi Pharma Corporation, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. Ando.Ryoichi@mk.m-pharma.co.jp